Clinical Trials Logo

Filter by:
NCT ID: NCT02509663 Terminated - Frontal Sinusitis Clinical Trials

Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons

SIBA
Start date: June 15, 2018
Phase: N/A
Study type: Interventional

The sinuplasty balloon offers a more physiological first of the sinuses which minimizes risks associated to traditional surgery. Its atraumatic characteristic also helps to reduce the risk of bleeding (so any use of Pack), limit scarring ransom, reduce the post-operative pain, ensure faster return to daily life activities (reduction of the average length of hospitalization). Patient's quality of life would be improved (SNOT-22 questionnaire) and reduction of post-operative pain score seams decrease on EVA. The economic impact of the sinuplasty balloon appears very favourable and fits into the strategy of development of the ambulatory practice.

NCT ID: NCT02509533 Terminated - Leg Ulcer Clinical Trials

Comparison of the Use of VAC System in Transplants of Leg Ulcers Versus Usual Dressing Method

Start date: September 2010
Phase: N/A
Study type: Interventional

To evaluate the VAC (Vacuum Assisted Closure) therapy in transplants of leg ulcers versus usual dressing method. The VAC Therapy system consists of: - A unit delivering a precise under atmospheric pressure, controlled and regulated in the wound site, - Consumables necessary for the implementation of the dressing, - Collecting tanks exudates with gel. VAC therapy is a system using negative pressure. It is known to be efficient into care of chronic wounds and ulcerous wounds by increasing the cicatrisation. This system is systematically used into the dermatology unit of the CHU of Saint-Etienne after transplants of leg ulcers, but no data confirms the interest of this method compared to usual dressing method. This study will provide this data.

NCT ID: NCT02509338 Terminated - Tardive Dystonia Clinical Trials

Validation of the Implantation of a New Electrode for the Treatment of Dystonia

MONOCONTACT
Start date: October 2013
Phase: N/A
Study type: Interventional

The main objective of the trial is to study the technical feasibility of the implantation of a new electrode Monocontact deep brain stimulation electrode in dystonia.

NCT ID: NCT02508649 Terminated - Septic Shock Clinical Trials

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

SEPSIS-ACT
Start date: July 2015
Phase: Phase 2/Phase 3
Study type: Interventional

This is a double-blind, randomised, placebo-controlled, two-part adaptive clinical trial. The trial is designed to investigate the efficacy and safety of multiple dosing regimens of selepressin and to confirm the efficacy and safety of one dosing regimen in treatment of adult patients with septic shock requiring vasopressor.

NCT ID: NCT02505087 Terminated - Clinical trials for Selenoprotein N-related Myopathy

Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)

SelNac
Start date: September 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to determine whether the administration of N-acetylcysteine (NAC) improves oxidative stress. To determine this, the study will assess the impact of oral treatment on the balance between reduced and oxidized form of glutathione in erythrocytes of peripheral blood.

NCT ID: NCT02504619 Terminated - Sickle Cell Disease Clinical Trials

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Start date: April 4, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

CordIn™ is a cryopreserved stem/progenitor cell-based product of purified CD133+ cells composed of ex vivo expanded allogeneic UCB cells. The overall study objectives are to evaluate the safety and efficacy of CordIn™.

NCT ID: NCT02502318 Terminated - Lung Cancer Clinical Trials

Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer

LungSco01
Start date: July 29, 2015
Phase: N/A
Study type: Interventional

This is a national study that involves the participation of 600 lung cancer patients indicated that treatment is ablation of the pulmonary lobe. This technique is called lobectomy. Lobectomy may be performed in two different ways: - Thoracotomy, which is the first reference approach and that is to make a large incision in the chest to pass between the ribs and spread the order to ablate the lobe. - By video-thoracoscopy, which is a new surgical approach consisting in practice several small incisions in the chest wall to allow the introduction of a camera and special instruments to ablate the lobe. The mini-invasive nature of video-thoracoscopy has a positive impact on postoperative expectoration and ventilation. As a result, the incidence of postoperative respiratory complications including atelectasis, pneumonia and Acute Respiratory Distress Syndrome (ARDS) is reduced. These respiratory complications are responsible for prolonged stays in Intensive Care Unit (ICU) and overall hospitalisation. It also has an impact on recovery and quality of life when patients return home. The reduction in the incidence of complications should counterbalance the additional cost of video-thoracoscopy. This study aims to evaluate the effectiveness of these two techniques in relation to the quality of life and the costs they generate. Patients who agree to participate in the study were assigned to one or other of these groups (technical thoracotomy or video-thoracoscopy technique) by lot.

NCT ID: NCT02501213 Terminated - Cancer Clinical Trials

Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)

Start date: May 30, 2016
Phase: Phase 2
Study type: Interventional

While some authors recommend diuretics as the first treatment to initiate for symptoms caused by malignant ascites (MA), their prescription is variable. No randomized, controlled study has assessed their benefit in this context. According to literature, diuretics may bring relief in about 40% of cases, regardless of primary tumor. The purpose of our study is to assess the effectiveness of diuretic treatment according to Serum Ascites Albumin Gradient (SAAG) measured before treatment. Judgment criteria is the time elapsed between recurrent MA that requires paracentesis. The investigators will also examine whether SAAG and serum levels of renin and aldosterone can predict symptom response to diuretics.

NCT ID: NCT02494778 Terminated - Clinical trials for Huntington's Disease

A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease

Open PRIDE-HD
Start date: September 24, 2015
Phase: Phase 2
Study type: Interventional

The purpose of the study is to collect and assess long term data on the safety, tolerability, and efficacy of pridopidine in patients with Huntington's disease (HD).

NCT ID: NCT02488954 Terminated - Ulcerative Colitis Clinical Trials

Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis

EMMENTAL
Start date: February 12, 2016
Phase: N/A
Study type: Interventional

Ulcerative colitis (UC) is an immune mediated chronic inflammatory bowel disease that results at least in part of an abnormal immune response to environmental factors including the intestinal microbiota. Thus, use of probiotics (microorganisms that are believed to provide health benefits when consume) may restore the gastrointestinal microbiota and reduce intestinal inflammation. Propionibacterium freudenreichii is used for the production of fermented food products (cheese). Some selected strains have strong anti-inflammatory properties. Use of cheese based on a monoxenic culture of anti-inflammatory strain of Propionibacterium freudenreichii may decrease disease activity during ulcerative colitis.